March 9, 2026

HCPA’s 2026 Mid-year meeting, May 12-14, 2026, Washington, D.C.

HCPA’s Mid-Year Meeting focuses on the public policy issues that impact the household and commercial products industry. Attendees will engage with a dynamic network of CEOs, executive decision-makers, and thought leaders who have knowledge, solutions, and influence across the entire supply chain. Richard E. Engler, Ph.D. and Ryan N. Schmit will present “TSCA Roundup – Latest from EPA, Congress, and the Courts.” B&C is a proud sponsor.
March 6, 2026

Canada Publishes Nanomaterials Risk Assessment Framework

On March 5, 2026, Environment and Climate Change Canada (ECCC) and Health Canada (HC) published the Framework for the Risk Assessment of Manufactured Nanomaterials under the Canadian Environmental Protection Act, 1999. According to Canada, the document establishes a framework for the risk assessment of nanomaterials under the Canadian Environmental Protection Act, 1999 (CEPA), including both existing nanomaterials on the Domestic Substances List (DSL), and new nanomaterials notified under the...
March 6, 2026

Senate Committee Examines Draft TSCA Legislation, Focusing on New Chemical Review

The Senate Committee on Environment and Public Works (EPW) held a hearing on a discussion draft of S.__, the Toxic Substances Control Act Fee Reauthorization and Improvement Act of 2026 (Discussion Draft) on March 4, 2026. The Committee’s one pager on the Discussion Draft notes that since the Toxic Substances Control Act (TSCA) was enacted 50 years ago, the U.S. Environmental Protection Agency’s (EPA) “approval process for new chemicals has not been substantively improved. The current...
March 6, 2026

Senate EPW Committee Examines Draft TSCA Fee Reauthorization and Improvement Act

On March 4, 2026, the U.S. Senate Committee on Environment and Public Works (EPW) held a legislative hearing to examine a discussion draft of the Toxic Substances Control Act Fee Reauthorization and Improvement Act of 2026. The hearing focused on reauthorizing Toxic Substances Control Act (TSCA) user fees that support the U.S. Environmental Protection Agency’s (EPA) chemical review programs and exploring potential reforms to the Agency’s new chemicals review process. The TSCA fee provisions...
March 5, 2026

USITC Will Investigate State Support and Pricing Practices by Chinese Biotechnology Firms

The U.S. International Trade Commission (USITC) announced on February 26, 2026, that it is undertaking a factfinding investigation to examine Chinese state support and pricing practices in the biotechnology sector and assess how these practices may be affecting the market share and competitiveness of the U.S. industry. USITC states that it is instituting this investigation, “Impact on U.S. Industry of China’s State Support and Pricing Practices in the Biotechnology Sector” (Inv. No....
March 5, 2026

New Modules and Expanded Courses Now Available in B&C’s TSCA Tutor® and FIFRA Tutor® Online Regulatory Training

Professionals seeking expert, efficient, essential regulatory training are encouraged to explore the offerings available from Bergeson & Campbell, P.C.’s (B&C®) TSCA Tutor® and FIFRA Tutor® online, on-demand courses. The courses were created to fill the gap between self-directed regulatory education and costly live training sessions. TSCA Tutor guides professionals through the Toxic Substances Control Act’s (TSCA) application to a company’s operations to ensure consistent...
March 5, 2026

The Relentless Pace of State PFAS Actions Discussed on B&C’s All Things Chemical® Podcast

Perhaps in response to perceived inaction at the federal level, over half of the U.S. states are engaged in per- and polyfluoroalkyl substances (PFAS) notification and restriction regulations. Bergeson & Campbell, P.C.’s (B&C®) All Things Chemical® podcast will cover the relentless pace of state PFAS regulation on the March 12, 2026, episode. B&C’s Lindsay A. Holden, Ph.D., DABT, Senior Toxicologist, and Carla N. Hutton, Senior Regulatory Analyst, join Managing Partner Lynn L....
March 4, 2026

Senate Bill Would Establish Federal Biotechnology Security Framework

On January 29, 2026, Senator Tom Cotton (R-AR) introduced the Biosecurity Modernization and Innovation Act of 2026 (S. 3741) to establish a federal biosecurity framework. According to Cotton’s February 4, 2026, press release, the bill “will require gene synthesis providers screen their orders and customers for bad actors or dangerous pathogens, and will ensure that the U.S. government adopts a flexible and agile approach to biosecurity that will ensure American leadership in biosecurity.”...
March 3, 2026

Glyphosate in Defense of America? AI Answers May Be Misleading? Who Knew?!

A February 18, 2026, Executive Order (EO) from President Trump, entitled “Promoting the National Defense by Ensuring an Adequate Supply of Elemental Phosphorus and Glyphosate-Based Herbicides,” concerns phosphorus’ use as a critical mineral in fertilizers for crop production (and the manufacture of explosives, among other things), and the role phosphorus plays in the production of the herbicide glyphosate, also used in crop production. Glyphosate is indeed important due to the way the...
March 3, 2026

EuropaBio Will Hold Webinar on Navigating Biotech SME Funding in Europe

On March 10, 2026, EuropaBio, the European Association for Bioindustries, will hold a webinar on “Navigating Biotech SME Funding: What’s available, How it works, What’s next for Europe.” According to EuropaBio, Europe’s biotech sector “continues to face significant financing challenges, especially during growth and scale‑up.” As the European Union (EU) moves forward with the landmark Biotech Act, the webinar will explore the funding tools available today, how companies can access...